Dostinex Alternatives Compared
| Dostinex (cabergoline) | Cabergoline | Bromocriptine |
|
|---|
| Dostinex (cabergoline) | Cabergoline | Bromocriptine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperprolactinemia. Dostinex may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperprolactinemia. Cabergoline may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperprolactinemia, Parkinson's Disease, Tardive Dyskinesia, Type 2 Diabetes, Acromegaly. Bromocriptine may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperprolactinemia
|
|||||||||||||||
| More about Dostinex (cabergoline) | More about Cabergoline | More about Bromocriptine | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Dostinex has an average rating of 8.4 out of 10 from a total of 19 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 0% reported a negative effect. |
Cabergoline has an average rating of 7.5 out of 10 from a total of 118 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 10% reported a negative effect. |
Bromocriptine has an average rating of 5.9 out of 10 from a total of 41 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Dostinex side effects |
View all Cabergoline side effects |
View all Bromocriptine side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cabergoline prices |
View all Bromocriptine prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Cycloset, Parlodel | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
100 hours |
100 hours |
8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 157 drugs are known to interact with Dostinex:
|
A total of 157 drugs are known to interact with Cabergoline:
|
A total of 461 drugs are known to interact with Bromocriptine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 23, 1996 |
December 23, 1996 |
June 28, 1978 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.